Optiscan has been featured in the Sydney Morning Herald, The Age, Brisbane Times and Bulls N' Bears regarding its September quarterly results which saw the company doubling its revenue. The article highlights that the company generated $670,000 in sales, a substantial increase from $287,000 in the previous quarter, driven by strong demand in the USA and Europe for its innovative imaging devices that diagnose cancer non-invasively.

Notably, Optiscan signed a Memorandum of Understanding (MOU) with the University of Minnesota College of Veterinary Medicine, emphasizing the growing interest in its technology within veterinary medicine. The partnership aims to leverage Optiscan's real-time in vivo imaging to improve cancer detection in companion animals and generate clinical data necessary for FDA clearance.

CEO Dr. Camile Farah expressed pride in the company’s milestones, stating, "Our recent advancements mark a significant step forward in our efforts to enhance diagnostic capabilities and drive innovation in medical imaging."

Sydney Morning Herald - Read the full article here.

The Age - Read the full article here.

Brisbane Times - Read the full article here.

Bulls N' Bears - Read the full article here.